Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 5
1993 5
1994 3
1995 2
1996 1
1997 1
1998 1
1999 4
2000 3
2001 1
2002 1
2003 2
2004 2
2005 5
2006 9
2007 5
2008 3
2009 4
2010 5
2011 1
2012 1
2013 2
2014 3
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Bortezomib as an antitumor agent.
Roccaro AM, Hideshima T, Richardson PG, Russo D, Ribatti D, Vacca A, Dammacco F, Anderson KC. Roccaro AM, et al. Curr Pharm Biotechnol. 2006 Dec;7(6):441-8. doi: 10.2174/138920106779116865. Curr Pharm Biotechnol. 2006. PMID: 17168660 Review.
Targeted therapy for multiple myeloma.
Anderson KC. Anderson KC. Semin Hematol. 2001 Jul;38(3):286-94. doi: 10.1016/s0037-1963(01)90021-6. Semin Hematol. 2001. PMID: 11486317 Review.
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma.
Görgün G, Samur MK, Cowens KB, Paula S, Bianchi G, Anderson JE, White RE, Singh A, Ohguchi H, Suzuki R, Kikuchi S, Harada T, Hideshima T, Tai YT, Laubach JP, Raje N, Magrangeas F, Minvielle S, Avet-Loiseau H, Munshi NC, Dorfman DM, Richardson PG, Anderson KC. Görgün G, et al. Clin Cancer Res. 2015 Oct 15;21(20):4607-18. doi: 10.1158/1078-0432.CCR-15-0200. Epub 2015 May 15. Clin Cancer Res. 2015. PMID: 25979485 Free PMC article.
SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERK.
Okawa Y, Hideshima T, Steed P, Vallet S, Hall S, Huang K, Rice J, Barabasz A, Foley B, Ikeda H, Raje N, Kiziltepe T, Yasui H, Enatsu S, Anderson KC. Okawa Y, et al. Blood. 2009 Jan 22;113(4):846-55. doi: 10.1182/blood-2008-04-151928. Epub 2008 Oct 23. Blood. 2009. PMID: 18948577 Free PMC article.
62 results